These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34688128)

  • 1. Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system.
    Romano E; Trionfini P; Giampietro R; Benigni A; Tomasoni S
    Stem Cell Res; 2021 Dec; 57():102580. PubMed ID: 34688128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey.
    Wang X; Lu M; Tian X; Ren Y; Li Y; Xiang M; Chen S
    Stem Cell Res Ther; 2020 Aug; 11(1):334. PubMed ID: 32746912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine.
    Trionfini P; Romano E; Varinelli M; Longaretti L; Rizzo P; Giampietro R; Caroli A; Aiello S; Todeschini M; Casiraghi F; Remuzzi G; Benigni A; Tomasoni S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.
    Kitano Y; Nishimura S; Kato TM; Ueda A; Takigawa K; Umekage M; Nomura M; Kawakami A; Ogawa H; Xu H; Hotta A; Takasu N; Tsukahara M
    Mol Ther Methods Clin Dev; 2022 Sep; 26():15-25. PubMed ID: 35755947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of PKD1 mono-allelic and bi-allelic knockout iPS cell lines using CRISPR-Cas9 system.
    Romano E; Trionfini P; Ciampi O; Benigni A; Tomasoni S
    Stem Cell Res; 2020 Jun; 47():101881. PubMed ID: 32592954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
    Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
    Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs.
    Li D; Ou M; Zhang W; Luo Q; Cai W; Mo C; Liang W; Dai G; Yin L; Zhu P; Tang D; Dai Y
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):131. PubMed ID: 37395026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9.
    Liu CL; Huang CY; Chen HC; Lu HE; Hsieh PCH; Lee JJ
    Stem Cell Res; 2020 May; 45():101784. PubMed ID: 32361310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
    Xu H; Wang B; Ono M; Kagita A; Fujii K; Sasakawa N; Ueda T; Gee P; Nishikawa M; Nomura M; Kitaoka F; Takahashi T; Okita K; Yoshida Y; Kaneko S; Hotta A
    Cell Stem Cell; 2019 Apr; 24(4):566-578.e7. PubMed ID: 30853558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface.
    Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N
    Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of porcine induced pluripotent stem cells and evaluation of their major histocompatibility complex protein expression in vitro.
    Park KM; Cha SH; Ahn C; Woo HM
    Vet Res Commun; 2013 Dec; 37(4):293-301. PubMed ID: 23975685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
    Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
    Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
    Wang H; Luo Y; Li J; Guan J; Yang S; Wang Q
    Stem Cell Res; 2022 Apr; 60():102736. PubMed ID: 35247837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future perspectives of HLA-edited induced pluripotent stem cells.
    Koga K; Wang B; Kaneko S
    Inflamm Regen; 2020; 40():23. PubMed ID: 33014207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
    Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
    Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of RAB4A homozygous knockout induced pluripotent stem cell (iPSC) line.
    Wang R; Shen Q
    Stem Cell Res; 2024 Dec; 81():103556. PubMed ID: 39299131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9.
    Vitale MR; Zöller JEM; Jansch C; Janz A; Edenhofer F; Klopocki E; van den Hove D; Vanmierlo T; Rivero O; Nadif Kasri N; Ziegler GC; Lesch KP
    Stem Cell Res; 2021 Mar; 51():102169. PubMed ID: 33486346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.